265 related articles for article (PubMed ID: 25394173)
21. Correspondence on "ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)" by Miller et al.
McGurk KA; Zheng SL; Henry A; Josephs K; Edwards M; de Marvao A; Whiffin N; Roberts A; Lumbers TR; O'Regan DP; Ware JS
Genet Med; 2022 Mar; 24(3):744-746. PubMed ID: 34906520
[No Abstract] [Full Text] [Related]
22. [Ethical issues in genome-era].
Kosugi S
Nihon Rinsho; 2016 Jun; 74(6):1022-7. PubMed ID: 27311196
[TBL] [Abstract][Full Text] [Related]
23. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.
Berg JS; Amendola LM; Eng C; Van Allen E; Gray SW; Wagle N; Rehm HL; DeChene ET; Dulik MC; Hisama FM; Burke W; Spinner NB; Garraway L; Green RC; Plon S; Evans JP; Jarvik GP;
Genet Med; 2013 Nov; 15(11):860-7. PubMed ID: 24195999
[TBL] [Abstract][Full Text] [Related]
24. A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing.
Berg JS; Foreman AK; O'Daniel JM; Booker JK; Boshe L; Carey T; Crooks KR; Jensen BC; Juengst ET; Lee K; Nelson DK; Powell BC; Powell CM; Roche MI; Skrzynia C; Strande NT; Weck KE; Wilhelmsen KC; Evans JP
Genet Med; 2016 May; 18(5):467-75. PubMed ID: 26270767
[TBL] [Abstract][Full Text] [Related]
25. "Not pathogenic until proven otherwise": perspectives of UK clinical genomics professionals toward secondary findings in context of a Genomic Medicine Multidisciplinary Team and the 100,000 Genomes Project.
Ormondroyd E; Mackley MP; Blair E; Craft J; Knight JC; Taylor JC; Taylor J; Watkins H
Genet Med; 2018 Mar; 20(3):320-328. PubMed ID: 29261176
[TBL] [Abstract][Full Text] [Related]
26. Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings.
Parsons DW; Roy A; Plon SE; Roychowdhury S; Chinnaiyan AM
J Clin Oncol; 2014 Jul; 32(21):2203-5. PubMed ID: 24958819
[No Abstract] [Full Text] [Related]
27. Consideration of Cosegregation in the Pathogenicity Classification of Genomic Variants.
Jarvik GP; Browning BL
Am J Hum Genet; 2016 Jun; 98(6):1077-1081. PubMed ID: 27236918
[TBL] [Abstract][Full Text] [Related]
28. Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Chung WK; Gordon AS; Herman GE; Klein TE; Stewart DR; Amendola LM; Adelman K; Bale SJ; Gollob MH; Harrison SM; Hershberger RE; McKelvey K; Richards CS; Vlangos CN; Watson MS; Martin CL;
Genet Med; 2021 Aug; 23(8):1582-1584. PubMed ID: 34345026
[No Abstract] [Full Text] [Related]
29. ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.
ACMG Board of Directors
Genet Med; 2015 Jan; 17(1):68-9. PubMed ID: 25356965
[TBL] [Abstract][Full Text] [Related]
30. Recommendations for returning genomic incidental findings? We need to talk!
Burke W; Antommaria AH; Bennett R; Botkin J; Clayton EW; Henderson GE; Holm IA; Jarvik GP; Khoury MJ; Knoppers BM; Press NA; Ross LF; Rothstein MA; Saal H; Uhlmann WR; Wilfond B; Wolf SM; Zimmern R
Genet Med; 2013 Nov; 15(11):854-9. PubMed ID: 23907645
[TBL] [Abstract][Full Text] [Related]
31. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
32. American College of Medical Genetics and Genomics: standards and guidelines for documenting suspected consanguinity as an incidental finding of genomic testing.
Rehder CW; David KL; Hirsch B; Toriello HV; Wilson CM; Kearney HM
Genet Med; 2013 Feb; 15(2):150-2. PubMed ID: 23328890
[TBL] [Abstract][Full Text] [Related]
33. PATH-SCAN: a reporting tool for identifying clinically actionable variants.
Daneshjou R; Zappala Z; Kukurba K; Boyle SM; Ormond KE; Klein TE; Snyder M; Bustamante CD; Altman RB; Montgomery SB
Pac Symp Biocomput; 2014; ():229-40. PubMed ID: 24297550
[TBL] [Abstract][Full Text] [Related]
34. CORRIGENDUM: Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Genet Med; 2017 Apr; 19(4):484. PubMed ID: 28383573
[No Abstract] [Full Text] [Related]
35. The cost-effectiveness of returning incidental findings from next-generation genomic sequencing.
Bennette CS; Gallego CJ; Burke W; Jarvik GP; Veenstra DL
Genet Med; 2015 Jul; 17(7):587-95. PubMed ID: 25394171
[TBL] [Abstract][Full Text] [Related]
36. Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC).
Mikhail FM; Biegel JA; Cooley LD; Dubuc AM; Hirsch B; Horner VL; Newman S; Shao L; Wolff DJ; Raca G
Genet Med; 2019 Sep; 21(9):1903-1916. PubMed ID: 31138931
[TBL] [Abstract][Full Text] [Related]
37. Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
Rehder C; Bean LJH; Bick D; Chao E; Chung W; Das S; O'Daniel J; Rehm H; Shashi V; Vincent LM;
Genet Med; 2021 Aug; 23(8):1399-1415. PubMed ID: 33927380
[TBL] [Abstract][Full Text] [Related]
38. Views of nonmedical, health system professionals regarding the return of whole genome sequencing incidental findings.
Strong KA; Zusevics KL; Bick DP; Veith R
WMJ; 2014 Oct; 113(5):179-84. PubMed ID: 25739160
[TBL] [Abstract][Full Text] [Related]
39. Management of Incidental Findings in Clinical Genomic Sequencing.
Krier JB; Green RC
Curr Protoc Hum Genet; 2015 Oct; 87():9.23.1-9.23.16. PubMed ID: 26439717
[TBL] [Abstract][Full Text] [Related]
40. Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing.
Allyse M; Michie M
Trends Biotechnol; 2013 Aug; 31(8):439-41. PubMed ID: 23664778
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
